<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.06513.004</object-id><label>Table 1.</label><caption><p>Infant demographics and clinical characteristics</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06513.004">http://dx.doi.org/10.7554/eLife.06513.004</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>All infants (N = 30)</th><th>0&#8211;3 M (n = 11)</th><th>4&#8211;6 M (n = 19)</th><th>Difference between medians in each age group</th><th>p-value</th></tr><tr><th colspan="6">Demographics</th></tr></thead><tbody><tr><td>PMA at birth (weeks)<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>39.0 (CI: 37.6&#8211;39.0)</td><td>37.0 (CI: 34.0&#8211;39.0)</td><td>39.0 (CI: 39.0&#8211;39.0)</td><td>2.0</td><td><bold>0.02</bold></td></tr><tr><td>PNA at study (months)<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>5.5 (CI: 3.6&#8211;6.1)</td><td>2.8 (CI: 0.5&#8211;3.5)</td><td>6.1 (CI: 5.5&#8211;6.1)</td><td>3.3</td><td>&#8211;</td></tr><tr><td>Weight at study (kg)<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>6.8 (CI: 6.1&#8211;7.6)</td><td>5.0 (CI: 4.1&#8211;6.3)</td><td>7.6 (CI: 6.7&#8211;8.2)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Male [%, (n)]<xref ref-type="table-fn" rid="tblfn2">&#8224;</xref></td><td>83.3 (25)</td><td>72.7 (8)</td><td>89.5 (17)</td><td>&#8211;</td><td>0.24</td></tr><tr><td colspan="6">Procedure type</td></tr><tr><td>General surgery [%, (n)]</td><td>53.3 (16)</td><td>90.9 (10)</td><td>31.6 (6)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Urological [%, (n)]</td><td>46.7 (14)</td><td>9.1 (1)</td><td>68.4 (13)</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td colspan="6">General anesthetic management</td></tr><tr><td>Nitrous oxide for induction [%, (n)]<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>76.7 (23)</td><td>54.5 (6)</td><td>94.7 (17)</td><td>&#8211;</td><td>0.07</td></tr><tr><td>Propofol [%, (n)]<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>36.7 (11)</td><td>27.3 (3)</td><td>42.1 (8)</td><td>&#8211;</td><td>0.47</td></tr><tr><td>Propofol cumulative dose (mg/kg)<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>15 (CI: 10&#8211;20)</td><td>10 (CI: 10-10)</td><td>15 (CI: 10&#8211;20)</td><td>5</td><td>0.08</td></tr><tr><td>Median duration of anesthesia (min)<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>108.5 (CI: 87&#8211;145)</td><td>118.0 (CI: 81&#8211;268)</td><td>94.0 (CI: 76&#8211;160)</td><td>&#8722;24.0</td><td>0.18</td></tr><tr><td colspan="6">MOSSA epoch detail</td></tr><tr><td>End-tidal sevoflurane (%)<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>2.6 (CI: 2.2&#8211;2.7)</td><td>2.0 (CI: 0.8&#8211;2.6)</td><td>2.6 (CI: 2.4&#8211;3.1)</td><td>0.7</td><td><bold>0.002</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Data given as median with 95% Confidence Interval (CI) Limit, unless otherwise stated. All infants included in MOSSA analysis. Six infants were excluded from the emergence analysis due to anesthetic management or technical reasons (<xref ref-type="fig" rid="fig2">Figure 2</xref>); 3 infants aged 0&#8211;3 months and 3 infants aged 4&#8211;6 months. 95% CI limit of median.</p></fn><fn><p>MOSSA, Maintenance Of a Surgical State of Anesthesia.</p></fn><fn id="tblfn1"><label>*</label><p>Mann&#8211;Whitney U-test.</p></fn><fn id="tblfn2"><label>&#8224;</label><p>Fisher's exact test.</p></fn><fn><p>p &lt; 0.05 considered statistically significant. <xref ref-type="supplementary-material" rid="SD1-data">Supplementary file 1</xref> provides characteristics for individual infants included in the analysis.</p></fn></table-wrap-foot></table-wrap>